HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Influence of FLG loss-of-function mutations in host-microbe interactions during atopic skin inflammation.

AbstractBACKGROUND:
Loss-of-function mutations in the filaggrin (FLG) gene directly alter skin barrier function and critically influence atopic inflammation. While skin barrier dysfunction, Th2-associated inflammation and bacterial dysbiosis are well-known characteristics of atopic dermatitis (AD), the mechanisms interconnecting genotype, transcriptome and microbiome remain largely elusive.
OBJECTIVE:
In-depth analysis of FLG genotype-associated skin gene expression alterations and host-microbe interactions in AD.
METHODS:
Multi-omics characterization of a cohort of AD patients carrying heterozygous loss-of-function mutations in the FLG gene (ADMut) (n = 15), along with matched wild-type (ADWt) patients and healthy controls. Detailed clinical characterization, microarray gene expression and 16 S rRNA-based microbial marker gene data were generated and analyzed.
RESULTS:
In the context of filaggrin dysfunction, the transcriptome was characterized by dysregulation of barrier function and water homeostasis, while the lesional skin of ADWt demonstrated the specific upregulation of pro-inflammatory cytokines and T-cell proliferation. S. aureus dominated the microbiome in both patient groups, however, shifting microbial communities could be observed when comparing healthy with non-lesional ADWt or ADMut skin, offering the opportunity to identify microbe-associated transcriptomic signatures. Moreover, an AD core signature with 28 genes, including CCL13, CCL18, BTC, SCIN, RAB31 and PCLO was identified.
CONCLUSIONS:
Our integrative approach provides molecular insights for the concept that FLG loss-of-function mutations are a genetic shortcut to atopic inflammation and unravels the complex interplay between genotype, transcriptome and microbiome in the human holobiont.
AuthorsPeter Oláh, Eszter Szlávicz, Marcus Kuchner, Jana Nemmer, Patrick Zeeuwen, Alain Lefèvre-Utile, Nanna Fyhrquist, Stefanie Prast-Nielsen, Tiina Skoog, Angela Serra, Elke Rodríguez, Ulrike Raap, Stephan Meller, Rolland Gyulai, Philippe Hupé, Juha Kere, Francesca Levi-Schaffer, Sophia Tsoka, Helen Alexander, Frank O Nestle, Jens M Schröder, Stephan Weidinger, Ellen van den Bogaard, Vassili Soumelis, Dario Greco, Jonathan Barker, Antti Lauerma, Annamari Ranki, Björn Andersson, Harri Alenius, Bernhard Homey
JournalJournal of dermatological science (J Dermatol Sci) Vol. 106 Issue 3 Pg. 132-140 (Jun 2022) ISSN: 1873-569X [Electronic] Netherlands
PMID35537882 (Publication Type: Journal Article)
CopyrightCrown Copyright © 2022. Published by Elsevier B.V. All rights reserved.
Chemical References
  • FLG protein, human
  • Filaggrin Proteins
  • Intermediate Filament Proteins
Topics
  • Dermatitis, Atopic (metabolism)
  • Filaggrin Proteins (metabolism)
  • Host Microbial Interactions (genetics)
  • Humans
  • Inflammation (genetics, metabolism)
  • Intermediate Filament Proteins (genetics, metabolism)
  • Mutation
  • Skin (metabolism)
  • Staphylococcus aureus

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: